Go to content
UR Home

Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study

Deutsch, Eric ; Kirzinger, Lukas ; Boy, Sandra ; Marienhagen, Jörg ; Schuierer, Gerhard ; Neu, Reiner ; Ried, Michael ; Hofmann, Hans-Stefan ; Wiebe, Karsten ; Ströbel, Philipp ; May, Christoph ; Kleylein-Sohn, Julia ; Baierlein, Claudia ; Bogdahn, Ulrich ; Marx, Alexander ; Schalke, Berthold



Abstract

Therapeutic options to cure advanced, recurrent, and unresectable thymomas are limited. The most important factor for long-term survival of thymoma patients is complete resection (R0) of the tumor. We therefore evaluated the response to and the induction of resectability of primarily or locally recurrent unresectable thymomas and thymic carcinomas by octreotide Long-Acting Release (LAR) plus ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons